全文获取类型
收费全文 | 5124篇 |
免费 | 428篇 |
出版年
2023年 | 6篇 |
2022年 | 31篇 |
2021年 | 79篇 |
2020年 | 36篇 |
2019年 | 48篇 |
2018年 | 80篇 |
2017年 | 62篇 |
2016年 | 118篇 |
2015年 | 187篇 |
2014年 | 208篇 |
2013年 | 279篇 |
2012年 | 367篇 |
2011年 | 357篇 |
2010年 | 284篇 |
2009年 | 259篇 |
2008年 | 334篇 |
2007年 | 387篇 |
2006年 | 321篇 |
2005年 | 321篇 |
2004年 | 310篇 |
2003年 | 284篇 |
2002年 | 270篇 |
2001年 | 53篇 |
2000年 | 32篇 |
1999年 | 75篇 |
1998年 | 84篇 |
1997年 | 56篇 |
1996年 | 58篇 |
1995年 | 55篇 |
1994年 | 62篇 |
1993年 | 47篇 |
1992年 | 56篇 |
1991年 | 36篇 |
1990年 | 32篇 |
1989年 | 17篇 |
1988年 | 30篇 |
1987年 | 23篇 |
1986年 | 19篇 |
1985年 | 25篇 |
1984年 | 21篇 |
1983年 | 22篇 |
1982年 | 21篇 |
1981年 | 21篇 |
1980年 | 15篇 |
1979年 | 16篇 |
1978年 | 10篇 |
1977年 | 11篇 |
1976年 | 8篇 |
1974年 | 6篇 |
1973年 | 7篇 |
排序方式: 共有5552条查询结果,搜索用时 31 毫秒
151.
Kevin Anderson Yi Chen Zhi Chen Romyr Dominique Kelli Glenn Yang He Cheryl Janson Kin-Chun Luk Christine Lukacs Ann Polonskaia Qi Qiao Aruna Railkar Pamela Rossman Hongmao Sun Qing Xiang Masha Vilenchik Peter Wovkulich Xiaolei Zhang 《Bioorganic & medicinal chemistry letters》2013,23(24):6610-6615
DYRK1B is a kinase over-expressed in certain cancer cells (including colon, ovarian, pancreatic, etc.). Recent publications have demonstrated inhibition of DYRK1B could be an attractive target for cancer therapy. From a data-mining effort, the team has discovered analogues of pyrido[2,3-d]pyrimidines as potent enantio-selective inhibitors of DYRK1B. Cells treated with a tool compound from this series showed the same cellular effects as down regulation of DYRK1B with siRNA. Such effects are consistent with the proposed mechanism of action. Progress of the SAR study is presented. 相似文献
152.
Renu Deswal Ravi Gupta Vivek Dogra Raksha Singh Jasmeet Kaur Abat Abhijit Sarkar Yogesh Mishra Vandana Rai Yelam Sreenivasulu Ramesh Sundar Amalraj Manish Raorane Ram Prasad Chaudhary Ajay Kohli Ashok Prabhakar Giri Niranjan Chakraborty Sajad Majeed Zargar Vishwanath Prasad Agrawal Ganesh Kumar Agrawal Dominique Job Jenny Renaut Randeep Rakwal 《Physiology and Molecular Biology of Plants》2013,19(4):461-477
Plant proteomics has made tremendous contributions in understanding the complex processes of plant biology. Here, its current status in India and Nepal is discussed. Gel-based proteomics is predominantly utilized on crops and non-crops to analyze majorly abiotic (49 %) and biotic (18 %) stress, development (11 %) and post-translational modifications (7 %). Rice is the most explored system (36 %) with major focus on abiotic mainly dehydration (36 %) stress. In spite of expensive proteomics setup and scarcity of trained workforce, output in form of publications is encouraging. To boost plant proteomics in India and Nepal, researchers have discussed ground level issues among themselves and with the International Plant Proteomics Organization (INPPO) to act in priority on concerns like food security. Active collaboration may help in translating this knowledge to fruitful applications. 相似文献
153.
Wei Xuan Evan Murphy Tom Beeckman Dominique Audenaert Ive De Smet 《Journal of chemical biology》2013,6(2):43-50
The application of small molecules has played a crucial role in identifying novel components involved in plant signalling. Compared to classic genetic approaches, small molecule screens offer notable advantages in dissecting plant biological processes, such as technical simplicity, low start-up costs, and most importantly, bypassing the problems of lethality and redundancy. To identify small molecules that target a biological process or protein of interest, robust and well-reasoned high-throughput screening approaches are essential. In this review, we present a series of principles and valuable approaches in small molecule screening in the plant model system Arabidopsis thaliana. We also provide an overview of small molecules that led to breakthroughs in uncovering phytohormone signalling pathways, endomembrane signalling cascades, novel growth regulators, and plant defence mechanisms. Meanwhile, the strategies to deciphering the mechanisms of these small molecules on Arabidopsis are highlighted. Moreover, the opportunities and challenges of small molecule applications in translational biology are discussed. 相似文献
154.
Issam Arrouss Fariba Nemati Fernando Roncal Marie Wislez Karim Dorgham David Vallerand Nathalie Rabbe Narjesse Karboul Fran?oise Carlotti Jeronimo Bravo Dominique Mazier Didier Decaudin Angelita Rebollo 《PloS one》2013,8(4)
Purpose
PP2A is a serine/threonine phosphatase critical to physiological processes, including apoptosis. Cell penetrating peptides are molecules that can translocate into cells without causing membrane damage. Our goal was to develop cell-penetrating fusion peptides specifically designed to disrupt the caspase-9/PP2A interaction and evaluate their therapeutic potential in vitro and in vivo.Experimental Design
We generated a peptide containing a penetrating sequence associated to the interaction motif between human caspase-9 and PP2A (DPT-C9h), in order to target their association. Using tumour cell lines, primary human cells and primary human breast cancer (BC) xenografts, we investigated the capacity of DPT-C9h to provoke apoptosis in vitro and inhibition of tumour growth (TGI) in vivo. DPT-C9h was intraperitonealy administered at doses from 1 to 25 mg/kg/day for 5 weeks. Relative Tumour Volume (RTV) was calculated.Results
We demonstrated that DPT-C9h specifically target caspase-9/PP2A interaction in vitro and in vivo and induced caspase-9-dependent apoptosis in cancer cell lines. DPT-C9h also induced significant TGI in BC xenografts models. The mouse-specific peptide DPT-C9 also induced TGI in lung (K-Ras model) and breast cancer (PyMT) models. DPT-C9h has a specific effect on transformed B cells isolated from chronic lymphocytic leukemia patients without any effect on primary healthy cells. Finally, neither toxicity nor immunogenic responses were observed.Conclusion
Using the cell-penetrating peptides blocking caspase-9/PP2A interactions, we have demonstrated that DPT-C9h had a strong therapeutic effect in vitro and in vivo in mouse models of tumour progression. 相似文献155.
Background
International collaboration (IC) is essential for the advance of stem cell research, a field characterized by marked asymmetries in knowledge and capacity between nations. China is emerging as a global leader in the stem cell field. However, knowledge on the extent and characteristics of IC in stem cell science, particularly China’s collaboration with developed economies, is lacking.Methods and Findings
We provide a scientometric analysis of the China–Canada collaboration in stem cell research, placing this in the context of other leading producers in the field. We analyze stem cell research published from 2006 to 2010 from the Scopus database, using co-authored papers as a proxy for collaboration. We examine IC levels, collaboration preferences, scientific impact, the collaborating institutions in China and Canada, areas of mutual interest, and funding sources. Our analysis shows rapid global expansion of the field with 48% increase in papers from 2006 to 2010. China now ranks second globally after the United States. China has the lowest IC rate of countries examined, while Canada has one of the highest. China–Canada collaboration is rising steadily, more than doubling during 2006–2010. China–Canada collaboration enhances impact compared to papers authored solely by China-based researchers This difference remained significant even when comparing only papers published in English.Conclusions
While China is increasingly courted in IC by developed countries as a partner in stem cell research, it is clear that it has reached its status in the field largely through domestic publications. Nevertheless, IC enhances the impact of stem cell research in China, and in the field in general. This study establishes an objective baseline for comparison with future studies, setting the stage for in-depth exploration of the dynamics and genesis of IC in stem cell research. 相似文献156.
Kayigan Wilson d’Almeida Dominique Pateron Gérald Kierzek Bertrand Renaud Caroline Semaille Pierre de Truchis Fran?ois Simon Judith Leblanc France Lert Stéphane Le Vu Anne-Claude Crémieux 《PloS one》2013,8(4)
Objective
We assessed the EDs’ characteristics associated with the offer and acceptance rates of a nontargeted HIV rapid-test screening in 29 Emergency Departments (EDs) in the metropolitan Paris region (11.7 million inhabitants), where half of France’s new HIV cases are diagnosed annually.Methods
EDs nurses offered testing to all patients 18–64-year-old, able to provide consent, either with or without supplemental staff (hybrid staff model or indigenous staff model). The EDS’ characteristics collected included structural characteristics (location, type, size), daily workload (patients’ number and severity, length of stay in hours), staff’s participation (training, support to the intervention, leadership), type of week day (weekends vs weekdays) and time (in days). Associations between these variables and the staff model, the offer and acceptance rates were studied using multilevel modeling.Results
Indigenous staff model was more frequent in EDs with a lower daily patient flow and a higher staff support score to the intervention. In indigenous-model EDs, the offer rate was associated with the patient flow (OR = 0.838, 95% CI = 0.773–0.908), was lower during weekends (OR = 0.623, 95% CI = 0.581–0.667) and decreased over time (OR = 0.978, 95% CI = 0.975–0.981). Similar results were found in hybrid-model EDs. Acceptance was poorly associated with EDs characteristics in indigenous-model EDs while in hybrid-model EDs it was lower during weekends (OR = 0.713, 95% CI = 0.623–0.816) and increased after the first positive test (OR = 1.526, 95% CI = 1.142–2.038).The EDs’ characteristics explained respectively 38.5% and 15% of the total variance in the offer rate across indigenous model-EDs and hybrid model-EDs vs 12% and 1% for the acceptance rate.Conclusion
Our findings suggest the need for taking into account EDs’ characteristics while considering the implementation of an ED-based HIV screening program. Strategies allowing the optimization of human resources’ utilization such as HIV targeted screening in the EDs might be privileged. 相似文献157.
158.
Benjamin Salmon Claire Bardet Mayssam Khaddam Jiar Naji Benjamin R. Coyac Brigitte Baroukh Franck Letourneur Julie Lesieur Franck Decup Dominique Le Denmat Antonino Nicoletti Anne Poliard Peter S. Rowe Eric Huet Sibylle Opsahl Vital Agnès Linglart Marc D. McKee Catherine Chaussain 《PloS one》2013,8(2)
Mutations in PHEX (phosphate-regulating gene with homologies to endopeptidases on the X-chromosome) cause X-linked familial hypophosphatemic rickets (XLH), a disorder having severe bone and tooth dentin mineralization defects. The absence of functional PHEX leads to abnormal accumulation of ASARM (acidic serine- and aspartate-rich motif) peptide − a substrate for PHEX and a strong inhibitor of mineralization − derived from MEPE (matrix extracellular phosphoglycoprotein) and other matrix proteins. MEPE-derived ASARM peptide accumulates in tooth dentin of XLH patients where it may impair dentinogenesis. Here, we investigated the effects of ASARM peptides in vitro and in vivo on odontoblast differentiation and matrix mineralization. Dental pulp stem cells from human exfoliated deciduous teeth (SHEDs) were seeded into a 3D collagen scaffold, and induced towards odontogenic differentiation. Cultures were treated with synthetic ASARM peptides (phosphorylated and nonphosphorylated) derived from the human MEPE sequence. Phosphorylated ASARM peptide inhibited SHED differentiation in vitro, with no mineralized nodule formation, decreased odontoblast marker expression, and upregulated MEPE expression. Phosphorylated ASARM peptide implanted in a rat molar pulp injury model impaired reparative dentin formation and mineralization, with increased MEPE immunohistochemical staining. In conclusion, using complementary models to study tooth dentin defects observed in XLH, we demonstrate that the MEPE-derived ASARM peptide inhibits both odontogenic differentiation and matrix mineralization, while increasing MEPE expression. These results contribute to a partial mechanistic explanation of XLH pathogenesis: direct inhibition of mineralization by ASARM peptide leads to the mineralization defects in XLH teeth. This process appears to be positively reinforced by the increased MEPE expression induced by ASARM. The MEPE-ASARM system can therefore be considered as a potential therapeutic target. 相似文献
159.
Thi My Lien Do Anh Vu Truong Thi Nga Vo Travis G. Pinnock Lawrence M. Pratt Dominique Guillaume Kim Phi Phung Nguyen 《Phytochemistry letters》2013,6(4):544-551
Boerhaavia diffusa L. is used in the traditional medicine of several Asian countries. The isolation and identification of five new compounds, together with 11 known compounds, from the ethyl acetate extract of the aerial part of B. diffusa grown Vietnam is reported. The structure of the new compounds was established by 1D and 2D NMR spectroscopy, and high resolution ESI-MS analysis. New compounds are two rotenoids: 9,11-dihydroxy-6,10-dimethoxy[1]benzopyrano[3,4-b][1]benzopyran-12(6H)-one (boeravinone P, 3) and 3-[2-(β-d-glucopyranosyloxy)-3-hydroxyphenyl]-5-hydroxy-2-hydroxymethyl-7-methoxy-6-methyl-4H-1-benzopyran-4-one (boeravinone Q, 9), an atropisomeric mixture of two rotenoid glycosides (3′,5-dihydroxy-2-hydroxymethyl-7-methoxy-6-methylisoflavone 2′-O-β-d-glucopyranoside, 11), a sesquiterpene lactone (4,10-dihydroxy-8-methoxyguai-7(11)-en-8,12-olide, 5) and a new phenylpropanoid glycoside (boerhaavic acid, 15). 相似文献